Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)

NCT03287076 is registered in ClinicalTrials.gov with Neuroscience Trials Australia as lead sponsor.

NCT NCT03287076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03287076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)
Lead sponsor
Neuroscience Trials Australia
Phase
Phase 2
Overall status
Unknown status
Start date
November 23, 2017
Completion date
December 31, 2021
Enrollment
350 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke